Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,637 USD | +3,75% |
|
+15,67% | -24,28% |
27/06 | Le azioni di X4 Pharmaceuticals cadono dopo l'annuncio di dati di prova sul trattamento delle malattie croniche del sangue | MT |
27/06 | Transcript : X4 Pharmaceuticals, Inc. - Special Call |
Attività
Numero di dipendenti: 116
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 01/07/14 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 01/09/18 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 01/01/17 |
Chief Tech/Sci/R&D Officer | - | 01/08/23 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/11/20 |
Murray Stewart
BRD | Director/Board Member | 63 | 29/03/19 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | 60 | 26/11/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 01/07/18 |
David McGirr
BRD | Director/Board Member | 69 | 01/09/17 |
Paula Ragan
FOU | Founder | 54 | 01/07/14 |
Gary Bridger
BRD | Director/Board Member | 61 | 01/10/18 |
Alison Lawton
BRD | Director/Board Member | 62 | 05/10/20 |
Bill Aliski
BRD | Director/Board Member | 75 | 18/09/19 |
Director/Board Member | 62 | 14/10/21 | |
Murray Stewart
BRD | Director/Board Member | 63 | 29/03/19 |
R. Woods
BRD | Director/Board Member | 56 | 01/09/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 167 937 781 | 162 460 401 ( 96,74 %) | 0 | 96,74 % |
Coordinate società
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.com![Indirizzo X4 Pharmaceuticals, Inc.(XFOR)](https://cdn.zonebourse.com/static/address/55942346.png)
Settore
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-24,28% | 103 Mln | |
+21,60% | 127 Mrd | |
+23,51% | 116 Mrd | |
+25,27% | 27,69 Mrd | |
-20,66% | 19,62 Mrd | |
-16,50% | 16,26 Mrd | |
-16,38% | 15,49 Mrd | |
+12,44% | 14,81 Mrd | |
-48,41% | 14,39 Mrd | |
+55,53% | 14,11 Mrd |
- Borsa valori
- Azioni
- Azione XFOR
- Società X4 Pharmaceuticals, Inc.